Oxybutynin significantly reduced hot flash frequency and severity compared with placebo among men with prostate cancer ...

The drug also treats an overactive bladder. Oxybutynin significantly reduced hot flashes in men receiving prostate cancer hormone therapy. Prostate cancer risk increases with age, but younger men may ...

“Oxybutynin demonstrated clear and clinically meaningful improvements in both hot flash frequency and quality of life for men undergoing hormone therapy for prostate cancer,” said Bradley J. Stish, MD ...

Vasomotor symptoms (VMS) including hot flashes are a common complaint among men undergoing androgen deprivation therapy (ADT) for prostate cancer. Although the symptoms are more widely associated with ...